Ignite Creation Date:
2024-07-17 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06467396
Status:
RECRUITING
Last Update Posted:
2024-06-21
First Post:
2024-06-14
Brief Title:
Blood Biomarkers to Predict the Prognosis of a Stroke Patient Undergoing Mechanical Thrombectomy
Sponsor:
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Organization:
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Study Overview
Official Title:
Blood Biomarkers to Predict the Prognosis of a Stroke Patient Undergoing Mechanical Thrombectomy
Status:
RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
TROMBOPOCT
Brief Summary:
The goal of this observational study is to evaluate the accuracy of a panel of blood biomarkers and clinical variables in predicting the prognosis of stroke patients treated by mechanical thrombectomy specifically to predict futile recanalization and mortality
Detailed Description:
Stroke is the leading cause of long-term disability and the second most common cause of death worldwide accounting for around 67 million deaths each year The burden of stroke due to illness disability and early death is set to double within the next 15 years due to an ageing population The socio-economical cost of the stroke is very high being around 45 million euros per year in Europe Although mechanical thrombectomy is the most effective treatment for stroke patients with large vessel occlusions still a large percentage of patients around 50 do not recover despite a successful recanalization the so called futile recanalization Therefore to anticipate the prognosis of patients treated with mechanical thrombectomy would be clinically relevant and very informative
This observational study evaluates the precision of a rapid test of blood biomarkers in the prognosis of stroke patients treated by mechanical thrombectomy For that the investigators will recruit a cohort of 400 consecutive patients treated by thrombectomy Using a multiplex POC for the biomarker measurement and an APP in combination with clinical data the potential of biomarkers to predict the prognosis of a patient will be determined
This observational study evaluates the precision of a rapid test of blood biomarkers in the prognosis of stroke patients treated by mechanical thrombectomy For that the investigators will recruit a cohort of 400 consecutive patients treated by thrombectomy Using a multiplex POC for the biomarker measurement and an APP in combination with clinical data the potential of biomarkers to predict the prognosis of a patient will be determined
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None